Marker X Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
17
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
3
Marker X General Information
Description
Operator of a biotechnology research and cancer screening facility intended to support early identification and prevention of cancer risk. The company specializes in the development of novel cancer protein markers for breast, lung, colorectal, and esophageal cancer, and offers AI proteomics early screening, and engages in scientific research and development of novel testing technologies, enabling healthcare professionals to access early detection and monitor potential cancer risk
Contact Information
Website
www.marker-x.comCorporate Office
- 5F., Number 348, Sector 7, Chengde Road
- Beitou
- Taipei City, 112
- Taiwan
Corporate Office
- 5F., Number 348, Sector 7, Chengde Road
- Beitou
- Taipei City, 112
- Taiwan
Marker X Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Accelerator/Incubator | 13-Mar-2026 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 03-Jun-2024 | Completed | Generating Revenue | |||
| 1. Grant | $700K | Completed | Pre-Clinical Trials |
Marker X Comparisons
Industry
Financing
Details
Marker X Competitors (5)
One of Marker X’s 5 competitors is Freenome, a Formerly VC-backed company based in Brisbane, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Freenome | Formerly VC-backed | Brisbane, CA | ||||
| Guardant Health | Formerly VC-backed | Palo Alto, CA | ||||
| Exact Sciences | Formerly VC-backed | Madison, WI | ||||
| Delfi Diagnostics | Venture Capital-Backed | Palo Alto, CA | ||||
| GRAIL | Formerly VC-backed | Menlo Park, CA |
Marker X Signals
Marker X Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| MedTech Accelerator | Accelerator/Incubator | |||
| UC Berkeley School of Public Health Innovation Accelerator Program | Accelerator/Incubator | |||
| Taiwan National Development Council | Government |
Marker X FAQs
-
When was Marker X founded?
Marker X was founded in 2020.
-
Where is Marker X headquartered?
Marker X is headquartered in Taipei City, Taiwan.
-
What is the size of Marker X?
Marker X has 17 total employees.
-
What industry is Marker X in?
Marker X’s primary industry is Laboratory Services (Healthcare).
-
Is Marker X a private or public company?
Marker X is a Private company.
-
What is Marker X’s current revenue?
The current revenue for Marker X is .
-
Who are Marker X’s investors?
MedTech Accelerator, UC Berkeley School of Public Health Innovation Accelerator Program, and Taiwan National Development Council have invested in Marker X.
-
Who are Marker X’s competitors?
Freenome, Guardant Health, Exact Sciences, Delfi Diagnostics, and GRAIL are competitors of Marker X.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process